Literature DB >> 30187114

[Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline].

Christoph Süß1, Oliver Kölbl2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30187114     DOI: 10.1007/s00066-018-1354-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  20 in total

1.  Extended surgical staging for potentially resectable malignant pleural mesothelioma.

Authors:  David C Rice; Jeremy J Erasmus; Craig W Stevens; Ara A Vaporciyan; Judy S Wu; Anne S Tsao; Garrett L Walsh; Stephen G Swisher; Wayne L Hofstetter; Nelson G Ordonez; W Roy Smythe
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

2.  Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.

Authors:  Jerôme Krayenbuehl; Susanne Oertel; J Bernard Davis; I Frank Ciernik
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

3.  Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a feasibility study.

Authors:  Marta Scorsetti; Mario Bignardi; Alessandro Clivio; Luca Cozzi; Antonella Fogliata; Paola Lattuada; Pietro Mancosu; Piera Navarria; Giorgia Nicolini; Gaetano Urso; Eugenio Vanetti; Sabrina Vigorito; Armando Santoro
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

4.  Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.

Authors:  Andrej Bece; Mo Mo Tin; Darren Martin; Robert Lin; Jocelyn McLean; Brian McCaughan
Journal:  J Med Imaging Radiat Oncol       Date:  2015-03-06       Impact factor: 1.735

5.  Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

Authors:  Kenneth E Rosenzweig; Marjorie G Zauderer; Benjamin Laser; Lee M Krug; Ellen Yorke; Camelia S Sima; Andreas Rimner; Raja Flores; Valerie Rusch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-18       Impact factor: 7.038

6.  Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients.

Authors:  L de Graaf-Strukowska; J van der Zee; W van Putten; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-02-01       Impact factor: 7.038

7.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

8.  Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Authors:  Marc de Perrot; Ronald Feld; Natasha B Leighl; Andrew Hope; Thomas K Waddell; Shaf Keshavjee; B C John Cho
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-19       Impact factor: 5.209

9.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

10.  Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.

Authors:  Christian Thieke; Nils H Nicolay; Florian Sterzing; Hans Hoffmann; Falk Roeder; Seyer Safi; Juergen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2015-12-30       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.